Raymond James Ups Accredo Health to 'Strong Buy'

Analyst John Ransom says damage to earnings estimates isn't nearly as severe as he had originally expected

Raymond James upgraded Accredo Health (ACDO ) to strong buy.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.